Sign in
4

Changes in Ownership

GeneDx Holdings Corp. Filed Acc 0001944119-25-000020

CHIEF FINANCIAL OFFICER sold 1,266 shares at $159.28 ($201,648)

  • CHIEF FINANCIAL OFFICER acquired 2,462 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Feeley Kevin · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-09 Exercise or conversion : show line 1 in the form +2,462 6,655 D
2025-12-09 Sale : show line 2 in the form −1,266 $159.28 $201,648 5,389 D
Open-market sales · 1,266 sh · avg $159.28 · $201,648

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-09 Exercise or conversion : show line 3 in the form Restricted Stock Unit −2,462 9,849 D
Loading xslF345X05/form4-12112025_091200.xml…